Who is missing from the measures? Trends in the proportion and treatment of patients potentially excluded from publicly reported quality measures

A sizeable and growing proportion of patients with AMI have relative contraindications to treatments that may result in discretionary exclusion from publicly reported quality measures. These patients represent a large population for which there is insufficient evidence as to whether measure exclusion or inclusion and treatment represents best care.